Noor Al Busaidi1, Prakash Shanmugam2, Deepa Manoharan2. 1. National Diabetes and Endocrine Centre, Royal Hospital, Muscat, Sultanate of Oman. doctoralbusaidi@gmail.com. 2. National Diabetes and Endocrine Centre, Royal Hospital, Muscat, Sultanate of Oman.
Abstract
PURPOSE OF REVIEW: Diabetes is a primary public health concern and a challenge for health decision makers in this century. Though the number of people with diabetes is increasing all over the globe, the very high prevalence of diabetes in many Middle East countries has made this region one of the global diabetes hot spots. Due to rapid socioeconomic growth, lifestyle changes and increasing obesity prevalence, the number of people with diabetes is expected to double by 2045 in this region. This high prevalence of diabetes imposes a substantial socioeconomic impact on the individual and governments in this region. The governments in the Middle East have devised many policies, programs, and strategies to address the growing prevalence of diabetes. In this article, we aim to review such policies, programs, and the magnitude of diabetes in this part of the world. RECENT FINDINGS: Faced with a challenge on a high scale, most governments in the Middle East are making progress in responding to diabetes. Diabetes is a chronic and costly disease; however, it can be prevented. The alarm of the rising tide of diabetes has not yet been successfully translated into action in the Middle East. The governments in the region need to devise more intense, broader policies and preventive measure programs based on local sociocultural practices to effectively combat the situation. Further improvements of the primary health care system and cross-governmental approaches are needed in the region to keep the growing epidemic of diabetes under control.
PURPOSE OF REVIEW: Diabetes is a primary public health concern and a challenge for health decision makers in this century. Though the number of people with diabetes is increasing all over the globe, the very high prevalence of diabetes in many Middle East countries has made this region one of the global diabetes hot spots. Due to rapid socioeconomic growth, lifestyle changes and increasing obesity prevalence, the number of people with diabetes is expected to double by 2045 in this region. This high prevalence of diabetes imposes a substantial socioeconomic impact on the individual and governments in this region. The governments in the Middle East have devised many policies, programs, and strategies to address the growing prevalence of diabetes. In this article, we aim to review such policies, programs, and the magnitude of diabetes in this part of the world. RECENT FINDINGS: Faced with a challenge on a high scale, most governments in the Middle East are making progress in responding to diabetes. Diabetes is a chronic and costly disease; however, it can be prevented. The alarm of the rising tide of diabetes has not yet been successfully translated into action in the Middle East. The governments in the region need to devise more intense, broader policies and preventive measure programs based on local sociocultural practices to effectively combat the situation. Further improvements of the primary health care system and cross-governmental approaches are needed in the region to keep the growing epidemic of diabetes under control.
Entities:
Keywords:
Diabetes; Diabetes prevention; Middle East region; Policy
Authors: Sawsan Al-Sinani; Ali Al-Mamari; Nicolas Woodhouse; Omaiyma Al-Shafie; Fatima Amar; Mohammed Al-Shafaee; Mohammed Hassan; Riad Bayoumi Journal: Oman Med J Date: 2015-01
Authors: H Elrayah-Eliadarous; K Yassin; M Eltom; S Abdelrahman; R Wahlström; C-G Ostenson Journal: Exp Clin Endocrinol Diabetes Date: 2010-02-05 Impact factor: 2.949
Authors: Azadeh Zabetian; Heval Mohamed Kelli; Justin B Echouffo-Tcheugui; K M Venkat Narayan; Mohammed K Ali Journal: Diabetes Res Clin Pract Date: 2013-05-01 Impact factor: 5.602
Authors: Nabil Sulaiman; Salah Elbadawi; Amal Hussein; Salah Abusnana; Abdulrazzag Madani; Maisoon Mairghani; Fatheya Alawadi; Ahmad Sulaiman; Paul Zimmet; Oliver Huse; Jonathan Shaw; Anna Peeters Journal: Diabetol Metab Syndr Date: 2017-11-02 Impact factor: 3.320
Authors: Wendy K Chung; Karel Erion; Jose C Florez; Andrew T Hattersley; Marie-France Hivert; Christine G Lee; Mark I McCarthy; John J Nolan; Jill M Norris; Ewan R Pearson; Louis Philipson; Allison T McElvaine; William T Cefalu; Stephen S Rich; Paul W Franks Journal: Diabetologia Date: 2020-09 Impact factor: 10.122
Authors: Fakhralddin Abbas Mohammed Elfakki; Mustafa Khidir Elnimeiri; Sami Mahmoud Assil; Ehab Ahmed Frah; Nada Hassan Ibrahim Abdalla Journal: J Family Med Prim Care Date: 2022-01-31